Find therapies in clinical trials near you – page 23

Study Comparing Vedolizumab and Infliximab for Children Aged 6-17 with Ulcerative Colitis

Study Comparing Vedolizumab and Infliximab for Children Aged 6-17 with Ulcerative Colitis

Study of Inebilizumab for Children and Adolescents with Neuromyelitis Optica Spectrum Disorder

Study of Inebilizumab for Children and Adolescents with Neuromyelitis Optica Spectrum Disorder

Study Comparing Avutometinib and Defactinib with Other Treatments for Patients with Recurrent Low-Grade Serous Ovarian Cancer

Study Comparing Avutometinib and Defactinib with Other Treatments for Patients with Recurrent Low-Grade Serous Ovarian Cancer

Study on the Safety and Effects of Divarasib with Pembrolizumab and a Drug Combination for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer with KRAS G12C Mutation

Study on the Safety and Effects of Divarasib with Pembrolizumab and a Drug Combination for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer with KRAS G12C Mutation

Study of NTLA-2001 for Patients with Transthyretin Amyloidosis and Heart Disease

Study of Amivantamab, Pembrolizumab, and Paclitaxel for Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Study of Amivantamab, Pembrolizumab, and Paclitaxel for Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Study on the Safety of Alprazolam for Treating Long Seizures in Patients Aged 12 and Older

Study on the Safety of Alprazolam for Treating Long Seizures in Patients Aged 12 and Older

Study Comparing Nemtabrutinib, Ibrutinib, and Acalabrutinib for Patients with Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Study Comparing Nemtabrutinib, Ibrutinib, and Acalabrutinib for Patients with Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Study of SP-420 for Patients with Transfusion-Dependent Alpha or Beta Thalassemia

Study of SP-420 for Patients with Transfusion-Dependent Alpha or Beta Thalassemia

Study on Tildrakizumab and Etanercept for Children Aged 6 to 17 with Moderate to Severe Plaque Psoriasis

Study on Tildrakizumab and Etanercept for Children Aged 6 to 17 with Moderate to Severe Plaque Psoriasis

Study on Balcinrenone and Dapagliflozin for Patients with Heart Failure and Kidney Problems

Study on Balcinrenone and Dapagliflozin for Patients with Heart Failure and Kidney Problems

Study on the Effectiveness of Concizumab for Children Under 12 with Hemophilia A or B, With or Without Inhibitors

Study on the Effectiveness of Concizumab for Children Under 12 with Hemophilia A or B, With or Without Inhibitors